Evidence map›Paper›PMID 33589781›Full record

ReviewNature biomedical engineering2021

Harnessing non-destructive 3D pathology.

Jonathan T C Liu, Adam K Glaser, Kaustav Bera, Lawrence D True, Nicholas P Reder, Kevin W Eliceiri, Anant Madabhushi

Abstract readReview
In one paragraph

Review in Nature biomedical engineering, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 83 papers.

0numbers the graph read from it
0cells of the map it votes in
83citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

83 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Assessing the Effects of a 3-Dimensional (3D) Pathology Tissue-Processing Workflow on Downstream Molecular Analyses.Laboratory investigation; a journal of technical methods and pathology · 2026
    Article
  5. Prototype-based AI triage for 3D pathology.bioRxiv : the preprint server for biology · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. 3D pathology-guided microdissection.bioRxiv : the preprint server for biology · 2025
    Article
  19. Article
  20. Article

23 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jonathan T C LiuDepartment of Mechanical Engineering, University of Washington, Seattle, WA, USA. jonliu@uw.edu.ORCID http://orcid.org/0000-0001-5650-3086
Adam K GlaserDepartment of Mechanical Engineering, University of Washington, Seattle, WA, USA.
Kaustav BeraDepartment of Biomedical Engineering, Case Western Reserve University, Cleveland, OH, USA.
Lawrence D TrueDepartment of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA.
Nicholas P RederDepartment of Mechanical Engineering, University of Washington, Seattle, WA, USA.
Kevin W EliceiriDepartment of Medical Physics, University of Wisconsin, Madison, WI, USA. eliceiri@wisc.edu.ORCID http://orcid.org/0000-0001-8678-670X
Anant MadabhushiDepartment of Biomedical Engineering, Case Western Reserve University, Cleveland, OH, USA. anant.madabhushi@case.edu.ORCID http://orcid.org/0000-0002-5741-0399

Funding

Center for Open Bioimage AnalysisP41GM135019 · NIGMS · BROAD INSTITUTE, INC. · PI CARPENTER, ANNE E. · 2020 to 2024
$6.9M
Pathology CoreU54CA254566 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI WILLIS, JOSEPH EDWARD · 2020 to 2024
$5.0M
Computer-Assisted Histologic Evaluation of Cardiac Allograft RejectionR01HL151277 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI MADABHUSHI, ANANT, MARGULIES, KENNETH BER · 2020 to 2023
$3.2M
Oral Cavity Quantitative Histomorphometric Risk Classifier (OHbIC) in Oral Cavity Squamous Cell Carcinoma (OC-SCC)R01CA249992 · NCI · EMORY UNIVERSITY · PI LEWIS, JAMES, MADABHUSHI, ANANT · 2021 to 2025
$3.2M
Computerized histologic image predictor of cancer outcomeR01CA202752 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI FELDMAN, MICHAEL D, GANESAN, SHRIDAR · 2016 to 2020
$3.1M
Quantitative Histomorphometric Risk Classifier (QuHbIC) in HPV + Oropharyngeal CarcinomaR01CA220581 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI KOYFMAN, SHLOMO, LEWIS, JAMES · 2018 to 2023
$3.1M
Computerized Histologic Risk Predictor (CHiRP) for Early Stage Lung CancersR01CA216579 · NCI · EMORY UNIVERSITY · PI FU, PINGFU, LLOYD, MARK · 2018 to 2023
$3.1M
MR Fingerprinting and Computerized Decision Support for Prostate CancerR01CA208236 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI GULANI, VIKAS, PONSKY, LEE EVAN · 2017 to 2022
$3.0M
Pathology Image Informatics Platform for visualization, analysis and managementU24CA199374 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI GURCAN, METIN NAFI, MADABHUSHI, ANANT · 2015 to 2019
$2.9M
In vivo dual-axis confocal microscopy of 5-ALA-induced PpIX to guide low-grade glioma resectionsR01CA244170 · NCI · UNIVERSITY OF WASHINGTON · PI LIU, JONATHAN T.C., SANAI, NADER · 2020 to 2024
$2.8M
Collagen structural changes as an early biomarker for breast carcinomaR01CA199996 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI CONKLIN, MATTHEW W · 2015 to 2019
$2.2M
Intraoperative confocal microscopy for quantitative delineation of low-grade glioR01CA175391 · NCI · UNIVERSITY OF WASHINGTON · PI LIU, JONATHAN T.C., SANAI, NADER · 2014 to 2018
$1.7M
BLRD VA I01 BX004121NCI NIH HHS K99 CA240681NCI NIH HHS R00 CA240681NCI NIH HHS R01 CA175391NCI NIH HHS R01 CA199996NCI NIH HHS R01 CA202752NCI NIH HHS R01 CA208236NCI NIH HHS R01 CA216579NCI NIH HHS R01 CA220581NCI NIH HHS R01 CA244170NCI NIH HHS R01 CA249992NCI NIH HHS U01 CA239055NCI NIH HHS U01 CA248226NCI NIH HHS U24 CA199374NCI NIH HHS U54 CA254566NCRR NIH HHS C06 RR012463NHLBI NIH HHS R01 HL151277NIBIB NIH HHS R43 EB028736NIGMS NIH HHS P41 GM135019
6 · The paper itself

Abstract

High-throughput methods for slide-free three-dimensional (3D) pathological analyses of whole biopsies and surgical specimens offer the promise of modernizing traditional histology workflows and delivering improvements in diagnostic performance. Advanced optical methods now enable the interrogation of orders of magnitude more tissue than previously possible, where volumetric imaging allows for enhanced quantitative analyses of cell distributions and tissue structures that are prognostic and predictive. Non-destructive imaging processes can simplify laboratory workflows, potentially reducing costs, and can ensure that samples are available for subsequent molecular assays. However, the large size of the feature-rich datasets that they generate poses challenges for data management and computer-aided analysis. In this Perspective, we provide an overview of the imaging technologies that enable 3D pathology, and the computational tools-machine learning, in particular-for image processing and interpretation. We also discuss the integration of various other diagnostic modalities with 3D pathology, along with the challenges and opportunities for clinical adoption and regulatory approval.

Indexed as

AnimalsBiopsyHumansImage Interpretation, Computer-AssistedImage Processing, Computer-AssistedMachine LearningPrognosis

Identifiers

PMID33589781
PMCPMC8118147

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.